{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T01:27:51Z","timestamp":1790040471034,"version":"4.0.1"},"reference-count":106,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T00:00:00Z","timestamp":1587513600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2020.00467","type":"journal-article","created":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T08:36:11Z","timestamp":1587544571000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["Dissecting the Epigenetic Changes Induced by Non-Antipsychotic Mood Stabilizers on Schizophrenia and Affective Disorders: A Systematic Review"],"prefix":"10.3389","volume":"11","author":[{"given":"Manuel","family":"Gardea-Resendez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Utku","family":"Kucuker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caren J.","family":"Blacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ada M.-C.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul E.","family":"Croarkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Frye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marin","family":"Veldic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,4,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1002\/ajmg.b.32691","article-title":"Aberrant transcriptomes and DNA methylomes define pathways that drive pathogenesis and loss of brain laterality\/asymmetry in schizophrenia and bipolar disorder","volume":"180","author":"Abdolmaleky","year":"2019","journal-title":"Am. J. Med. Genet. B. Neuropsychiatr. Genet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.brainresrev.2006.04.001","article-title":"Molecular and cellular mechanisms of altered GAD1\/GAD67 expression in schizophrenia and related disorders","volume":"52","author":"Akbarian","year":"2006","journal-title":"Brain Res. Rev."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms19103026","article-title":"DNA Methylation as a Biomarker of Treatment Response Variability in Serious Mental Illnesses: A Systematic Review Focused on Bipolar Disorder, Schizophrenia, and Major Depressive Disorder","volume":"19","author":"Alladi","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/nrg.2016.59","article-title":"The molecular hallmarks of epigenetic control","volume":"17","author":"Allis","year":"2016","journal-title":"Nat. Rev. Genet."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1017\/S1461145713000710","article-title":"Effect of mood stabilizers on DNA methylation in human neuroblastoma cells","volume":"16","author":"Asai","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.euroneuro.2017.06.002","article-title":"Epigenetic induction of melatonin MT1 receptors by valproate: Neurotherapeutic implications","volume":"27","author":"Bahna","year":"2017","journal-title":"Eur. Neuropsychopharmacol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.neuropharm.2015.06.018","article-title":"Valproic acid exposure leads to upregulation and increased promoter histone acetylation of sepiapterin reductase in a serotonergic cell line","volume":"99","author":"Balasubramanian","year":"2015","journal-title":"Neuropharmacology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.pharep.2015.04.004","article-title":"Valproic acid (VPA) reduces sensorimotor gating deficits and HDAC2 overexpression in the MAM animal model of schizophrenia","volume":"67","author":"Bator","year":"2015","journal-title":"Pharmacol. Rep."},{"key":"B9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1176\/appi.ajp.161.1.3","article-title":"What is a \u201cmood stabilizer\u201d? An evidence-based response","volume":"161","author":"Bauer","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"B10","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1080\/15622975.2016.1231421","article-title":"Is the molecular clock ticking differently in bipolar disorder? Methylation analysis of the clock gene ARNTL","volume":"19","author":"Bengesser","year":"2018","journal-title":"World J. Biol. Psychiatry"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1038\/nbt1010-1045","article-title":"The NIH Roadmap Epigenomics Mapping Consortium","volume":"28","author":"Bernstein","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.pharmthera.2014.11.016","article-title":"Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases","volume":"148","author":"Beurel","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"B13","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.schres.2018.02.036","article-title":"Regulatory characterisation of the schizophrenia-associated CACNA1C proximal promoter and the potential role for the transcription factor EZH2 in schizophrenia aetiology","volume":"199","author":"Billingsley","year":"2018","journal-title":"Schizophr. Res."},{"key":"B14","first-page":"1","article-title":"EAAT2 as a Research Target in Bipolar Disorder and Unipolar Depression: A Systematic Review","volume-title":"Mol. Neuropsychiatry","author":"Blacker","year":"2019"},{"key":"B15","doi-asserted-by":"publisher","first-page":"343","DOI":"10.2217\/epi.15.5","article-title":"DNA methylation, insulin resistance and second-generation antipsychotics in bipolar disorder","volume":"7","author":"Burghardt","year":"2015","journal-title":"Epigenomics"},{"key":"B16","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1111\/bdi.12422","article-title":"Gene-specific DNA methylation may mediate atypical antipsychotic-induced insulin resistance","volume":"18","author":"Burghardt","year":"2016","journal-title":"Bipolar Disord."},{"key":"B17","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s00213-012-2900-0","article-title":"Modulation of neuronal plasticity following chronic concomitant administration of the novel antipsychotic lurasidone with the mood stabilizer valproic acid","volume":"226","author":"Calabrese","year":"2013","journal-title":"Psychopharmacology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nrg2540","article-title":"Linking DNA methylation and histone modification: patterns and paradigms","volume":"10","author":"Cedar","year":"2009","journal-title":"Nat. Rev. Genet."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1042\/Bst0371415","article-title":"GABRB2 in schizophrenia and bipolar disorder: disease association, gene expression and clinical correlations","volume":"37","author":"Chen","year":"2009","journal-title":"Biochem. Soc. Trans."},{"key":"B20","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.psychres.2014.12.020","article-title":"Bcl-2 associated with severity of manic symptoms in bipolar patients in a manic phase","volume":"225","author":"Chen","year":"2015","journal-title":"Psychiatry Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1038\/mp.2017.217","article-title":"Co-aggregation of major psychiatric disorders in individuals with first-degree relatives with schizophrenia: a nationwide population-based study","volume":"23","author":"Cheng","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"B22","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.euroneuro.2012.01.005","article-title":"The Schizophrenia and Bipolar Disorder associated BRD1 gene is regulated upon chronic restraint stress","volume":"22","author":"Christensen","year":"2012","journal-title":"Eur. Neuropsychopharmacol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.cell.2004.12.020","article-title":"Thrombospondins are astrocyte-secreted proteins that promote CNS synaptogenesis","volume":"120","author":"Christopherson","year":"2005","journal-title":"Cell"},{"key":"B24","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1034\/j.1399-5618.2002.01179.x","article-title":"Neuroprotective effects of lithium in cultured cells and animal models of diseases","volume":"4","author":"Chuang","year":"2002","journal-title":"Bipolar Disord."},{"key":"B25","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.conb.2007.01.011","article-title":"Neurexin-neuroligin signaling in synapse development","volume":"17","author":"Craig","year":"2007","journal-title":"Curr. Opin. Neurobiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1016\/S0140-6736(12)62129-1","article-title":"Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis","volume":"381","year":"2013","journal-title":"Lancet (London Engl.)"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1038\/npp.2012.10","article-title":"Selective DNA Methylation of BDNF Promoter in Bipolar Disorder: Differences Among Patients with BDI and BDII","volume":"37","author":"D\u2019Addario","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"B28","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/nrn2075","article-title":"Cell adhesion molecules: signalling functions at the synapse","volume":"8","author":"Dalva","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/gb-2012-13-6-r43","article-title":"Functional annotation of the human brain methylome identifies tissue-specific epigenetic variation across brain and blood","volume":"13","author":"Davies","year":"2012","journal-title":"Genome Biol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.jad.2014.05.020","article-title":"Epigenetic modulation of BDNF gene: differences in DNA methylation between unipolar and bipolar patients","volume":"166","author":"Dell\u2019Osso","year":"2014","journal-title":"J. Affect. Disord."},{"key":"B31","doi-asserted-by":"publisher","first-page":"12578","DOI":"10.1073\/pnas.0505394102","article-title":"Reelin and glutamic acid decarboxylase(67) promoter remodeling in an epigenetic methionine-induced mouse model of schizophrenia","volume":"102","author":"Dong","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. States America"},{"key":"B32","doi-asserted-by":"publisher","first-page":"730","DOI":"10.4161\/epi.5.8.13053","article-title":"Valproate induces DNA demethylation in nuclear extracts from adult mouse brain","volume":"5","author":"Dong","year":"2010","journal-title":"Epigenetics"},{"key":"B33","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3238\/arztebl.2009.0100","article-title":"Critical appraisal of scientific articles: part 1 of a series on evaluation of scientific publications","volume":"106","author":"du Prel","year":"2009","journal-title":"Dtsch Arztebl Int."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnins.2014.00457","article-title":"Lithium-induced neuroprotection is associated with epigenetic modification of specific BDNF gene promoter and altered expression of apoptotic-regulatory proteins","volume":"8","author":"Dwivedi","year":"2015","journal-title":"Front. Neurosci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0170121","article-title":"DNA Methylation Analysis of BRD1 Promoter Regions and the Schizophrenia rs138880 Risk Allele","volume":"12","author":"Dyrvig","year":"2017","journal-title":"PloS One"},{"key":"B36","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.neulet.2019.04.015","article-title":"DNA methylation regulates CHRNA7 transcription and can be modulated by valproate","volume":"704","author":"Dyrvig","year":"2019","journal-title":"Neurosci. Lett."},{"key":"B37","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1111\/j.0013-9580.2004.00104.x","article-title":"The activity of antiepileptic drugs as histone deacetylase inhibitors","volume":"45","author":"Eyal","year":"2004","journal-title":"Epilepsia"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jpsychires.2014.09.014","article-title":"Specific and common genes implicated across major mental disorders: A review of meta-analysis studies","volume":"60","author":"Gatt","year":"2015","journal-title":"J. Psychiatr. Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.neubiorev.2009.10.010","article-title":"Histone modifications, DNA methylation, and Schizophrenia","volume":"34","author":"Gavin","year":"2010","journal-title":"Neurosci. Biobehav. Rev."},{"key":"B40","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.jpsychires.2008.12.006","article-title":"Histone deacetylase inhibitors and candidate gene expression: An in vivo and in vitro approach to studying chromatin remodeling in a clinical population","volume":"43","author":"Gavin","year":"2009","journal-title":"J.\u00a0Psychiatr. Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1017\/S1461145710000805","article-title":"Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders","volume":"14","author":"Gawryluk","year":"2011","journal-title":"Int. J.\u00a0Neuropsychopharmacol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.biopsych.2018.09.006","article-title":"Clock Genes and Light Signaling Alterations in Bipolar Disorder: When the Biological Clock Is Off","volume":"84","author":"Geoffroy","year":"2018","journal-title":"Biol. Psychiatry"},{"key":"B43","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1017\/S0033291706009305","article-title":"What is a mood stabilizer","volume":"37","author":"Goodwin","year":"2007","journal-title":"psychol. Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","article-title":"Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells","volume":"20","author":"Gottlicher","year":"2001","journal-title":"EMBO J."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/archpsyc.57.11.1061","article-title":"Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study","volume":"57","author":"Guidotti","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"key":"B46","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3389\/fncel.2016.00089","article-title":"Epigenetic RELN Dysfunction in Schizophrenia and Related Neuropsychiatric Disorders","volume":"10","author":"Guidotti","year":"2016","journal-title":"Front. Cell. Neurosci."},{"key":"B47","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1177\/0269881114553647","article-title":"Recent genetic findings in schizophrenia and their therapeutic relevance","volume":"29","author":"Harrison","year":"2015","journal-title":"J. Psychopharmacol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/j.jpsychires.2011.04.008","article-title":"State-dependent changes in the expression of DNA methyltransferases in mood disorder patients","volume":"45","author":"Higuchi","year":"2011","journal-title":"J. Psychiatr. Res."},{"key":"B49","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jpsychires.2009.08.015","article-title":"Altered gene expression of histone deacetylases in mood disorder patients","volume":"44","author":"Hobara","year":"2010","journal-title":"J. Psychiatr. Res."},{"key":"B50","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/npp.2012.78","article-title":"Epigenetics in the Human Brain","volume":"38","author":"Houston","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"B51","doi-asserted-by":"publisher","first-page":"197","DOI":"10.2217\/epi.15.98","article-title":"DNA methylation signatures of mood stabilizers and antipsychotics in bipolar disorder","volume":"8","author":"Houtepen","year":"2016","journal-title":"Epigenomics"},{"key":"B52","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1017\/S1461145713001569","article-title":"Decreased global methylation in patients with bipolar disorder who respond to lithium","volume":"17","author":"Huzayyin","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.fertnstert.2013.01.117","article-title":"Basic concepts of epigenetics","volume":"99","author":"Inbar-Feigenberg","year":"2013","journal-title":"Fertil. Sterility"},{"key":"B54","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/ng1235","article-title":"Impaired feedback regulation of XBP1 as a genetic risk factor for bipolar disorder","volume":"35","author":"Kakiuchi","year":"2003","journal-title":"Nat. Genet."},{"key":"B55","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/bdi.12230","article-title":"DNA methylation and expression of KCNQ3 in bipolar disorder","volume":"17","author":"Kaminsky","year":"2015","journal-title":"Bipolar Disord."},{"key":"B56","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/jnc.12292","article-title":"The mood stabilizer valproate activates human FGF1 gene promoter through inhibiting HDAC and GSK-3 activities","volume":"126","author":"Kao","year":"2013","journal-title":"J. Neurochem."},{"key":"B57","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ejphar.2008.04.058","article-title":"Clinically relevant concentrations of valproic acid modulate melatonin MT(1) receptor, HDAC and MeCP2 mRNA expression in C6 glioma cells","volume":"589","author":"Kim","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"5404","DOI":"10.1523\/Jneurosci.4893-09.2010","article-title":"Neuronal Pentraxins Mediate Silent Synapse Conversion in the Developing Visual System","volume":"30","author":"Koch","year":"2010","journal-title":"J. Neurosci."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/tp.2015.90","article-title":"Search for common targets of lithium and valproic acid identifies novel epigenetic effects of lithium on the rat leptin receptor gene","volume":"5","author":"Lee","year":"2015","journal-title":"Trans. Psychiatry"},{"key":"B60","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.1523\/Jneurosci.5467-07.2008","article-title":"Synergistic neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: Roles of glycogen synthase kinase-3 inhibition","volume":"28","author":"Leng","year":"2008","journal-title":"J. Neurosci."},{"key":"B61","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1017\/S1461145712000429","article-title":"Neuroprotective effects of the mood stabilizer lamotrigine against glutamate excitotoxicity: roles of chromatin remodelling and Bcl-2 induction","volume":"16","author":"Leng","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ijnp\/pyw035","article-title":"Valproic Acid and Other HDAC Inhibitors Upregulate FGF21 Gene Expression and Promote Process Elongation in Glia by Inhibiting HDAC2 and 3","volume":"19","author":"Leng","year":"2016","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1177\/1535370213513987","article-title":"Histone acetylation and expression of mono-aminergic transmitters synthetases involved in CUS-induced depressive rats","volume":"239","author":"Liu","year":"2014","journal-title":"Exp. Biol. Med."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/0471142301.ns0943s63","article-title":"The MAM rodent model of schizophrenia","volume":"9","author":"Lodge","year":"2013","journal-title":"Curr. Protoc. Neurosci."},{"key":"B65","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/sj.mp.4002088","article-title":"Meta-analyses of genetic studies on major depressive disorder","volume":"13","author":"Lopez-Leon","year":"2008","journal-title":"Mol. Psychiatry"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1038\/mp.2016.123","article-title":"Dissecting bipolar disorder complexity through epigenomic approach","volume":"21","author":"Ludwig","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"B67","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1111\/j.1755-5949.2010.00203.x","article-title":"Histone deacetylases and mood disorders: epigenetic programming in gene-environment interactions","volume":"17","author":"Machado-Vieira","year":"2011","journal-title":"CNS Neurosci. Ther."},{"key":"B68","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jad.2017.12.026","article-title":"Lithium, Stress, and Resilience in Bipolar Disorder: Deciphering this key homeostatic synaptic plasticity regulator","volume":"233","author":"Machado-Vieira","year":"2018","journal-title":"J. Affect. Disord."},{"key":"B69","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.euroneuro.2013.05.013","article-title":"Prenatal MAM administration affects histone H3 methylation in postnatal life in the rat medial prefrontal cortex","volume":"24","author":"Mackowiak","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1016\/S0140-6736(18)31948-2","article-title":"Depression","volume":"392","author":"Malhi","year":"2018","journal-title":"Lancet"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1111\/gbb.12483","article-title":"Distinct chromatin structures at the monoamine oxidase-A promoter correlate with allele-specific expression in SH-SY5Y cells","volume":"18","author":"Manca","year":"2019","journal-title":"Genes Brain Behav."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1056\/NEJMra1808803","article-title":"Schizophrenia","volume":"381","author":"Marder","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"B73","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1124\/mol.110.070896","article-title":"Activation of Group II Metabotropic Glutamate Receptors Promotes DNA Demethylation in the Mouse Brain","volume":"80","author":"Matrisciano","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1093\/schbul\/sby096","article-title":"CACNA1C: Association With Psychiatric Disorders, Behavior, and Neurogenesis","volume":"44","author":"Moon","year":"2018","journal-title":"Schizophr. Bull."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/j.jpsychires.2013.05.028","article-title":"Antidepressants and mood stabilizers effects on histone deacetylase expression in C57BL\/6 mice: Brain region specific changes","volume":"47","author":"Ookubo","year":"2013","journal-title":"J. Psychiatr. Res."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan-a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst. Rev."},{"key":"B77","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/npp.2009.188","article-title":"Valproate and Amitriptyline Exert Common and Divergent Influences on Global and Gene Promoter-Specific Chromatin Modifications in Rat Primary Astrocytes","volume":"35","author":"Perisic","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"B78","doi-asserted-by":"publisher","first-page":"36734","DOI":"10.1074\/jbc.M101287200","article-title":"Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen","volume":"276","author":"Phiel","year":"2001","journal-title":"J. Biol. Chem."},{"key":"B79","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.neulet.2016.06.045","article-title":"Understanding the molecular mechanisms underlying mood stabilizer treatments in bipolar disorder: Potential involvement of epigenetics","volume":"669","author":"Pisanu","year":"2018","journal-title":"Neurosci. Lett."},{"key":"B80","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1074\/jbc.M114.603761","article-title":"Dual Roles of Histone H3 Lysine 9 Acetylation in Human Embryonic Stem Cell Pluripotency and Neural Differentiation","volume":"290","author":"Qiao","year":"2015","journal-title":"J. Biol. Chem."},{"key":"B81","doi-asserted-by":"publisher","first-page":"675","DOI":"10.4088\/JCP.12r08046","article-title":"Lamotrigine in Psychiatric Disorders","volume":"74","author":"Reid","year":"2013","journal-title":"J. Clin. Psychiatry"},{"key":"B82","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1093\/nar\/gkv090","article-title":"H3K4me3 demethylation by the histone demethylase KDM5C\/JARID1C promotes DNA replication origin firing","volume":"43","author":"Rondinelli","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/tp.2017.83","article-title":"Perturbations in the apoptotic pathway and mitochondrial network dynamics in peripheral blood mononuclear cells from bipolar disorder patients","volume":"7","author":"Scaini","year":"2017","journal-title":"Trans. Psychiatry"},{"key":"B84","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1055\/s-0036-1593849","article-title":"Constitutional Epi\/Genetic Conditions: Genetic, Epigenetic, and Environmental Factors","volume":"6","author":"Schenkel","year":"2017","journal-title":"J. Pediatr. Genet."},{"key":"B85","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/sj.npp.1301575","article-title":"Cellular plasticity cascades in the pathophysiology and treatment of bipolar disorder","volume":"33","author":"Schloesser","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"B86","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.tins.2011.11.009","article-title":"Mood-stabilizing drugs: mechanisms of action","volume":"35","author":"Schloesser","year":"2012","journal-title":"Trends Neurosci."},{"key":"B87","doi-asserted-by":"publisher","first-page":"94","DOI":"10.9758\/cpn.2014.12.2.94","article-title":"Potential Molecular and Cellular Mechanism of Psychotropic Drugs","volume":"12","author":"Seo","year":"2014","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"B88","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1038\/mp.2008.29","article-title":"The genetics of bipolar disorder: genome \u2018hot regions,\u2019 genes, new potential candidates and future directions","volume":"13","author":"Serretti","year":"2008","journal-title":"Mol. Psychiatry"},{"key":"B89","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1146\/annurev.biochem.76.052705.162114","article-title":"Functions of Site-Specific Histone Acetylation and Deacetylation","volume":"76","author":"Shahbazian","year":"2007","journal-title":"Annu. Rev. Biochem."},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g7647","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation","volume":"350","author":"Shamseer","year":"2015","journal-title":"BMJ"},{"key":"B91","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.schres.2008.12.017","article-title":"Association of the 5\u2032-upstream regulatory region of the alpha7 nicotinic acetylcholine receptor subunit gene (CHRNA7) with schizophrenia","volume":"109","author":"Stephens","year":"2009","journal-title":"Schizophr. Res."},{"key":"B92","doi-asserted-by":"publisher","first-page":"17095","DOI":"10.1073\/pnas.262658999","article-title":"An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability","volume":"99","author":"Tremolizzo","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. States America"},{"key":"B93","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.biopsych.2004.11.046","article-title":"Valproate corrects the schizophrenia-like epigenetic behavioral modifications induced by methionine in mice","volume":"57","author":"Tremolizzo","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"B94","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.psychres.2013.08.032","article-title":"Bcl-2 associated with positive symptoms of schizophrenic patients in an acute phase","volume":"210","author":"Tsai","year":"2013","journal-title":"Psychiatry Res."},{"key":"B95","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1073\/pnas.2637013100","article-title":"DNA-methyltransferase 1 mRNA is selectively overexpressed in telencephalic GABAergic interneurons of schizophrenia brains","volume":"101","author":"Veldic","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. States America"},{"key":"B96","doi-asserted-by":"publisher","first-page":"18008","DOI":"10.1038\/nrdp.2018.8","article-title":"Bipolar disorders","volume":"4","author":"Vieta","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"B97","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S2215-0366(15)00505-2","article-title":"Estimating the true global burden of mental illness","volume":"3","author":"Vigo","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"B98","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.pnpbp.2012.01.017","article-title":"Valproic acid mediates the synaptic excitatory\/inhibitory balance through astrocytes - A preliminary study","volume":"37","author":"Wang","year":"2012","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ijnp\/pyv054","article-title":"A Methionine-Induced Animal Model of Schizophrenia: Face and Predictive Validity","volume":"18","author":"Wang","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3791\/52587","article-title":"The forced swim test as a model of depressive-like behavior","volume":"97","author":"Yankelevitch-Yahav","year":"2015","journal-title":"J. Vis. Exp."},{"key":"B101","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/bdi.12609","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder","volume":"20","author":"Yatham","year":"2018","journal-title":"Bipolar Disord."},{"key":"B102","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.jad.2013.11.010","article-title":"Influence of BCL2 gene in major depression susceptibility and antidepressant treatment outcome","volume":"155","author":"Zhang","year":"2014","journal-title":"J. Affect. Disord."},{"key":"B103","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.schres.2011.11.029","article-title":"Epigenetic regulation on GABRB2 isoforms expression: Developmental variations and disruptions in psychotic disorders","volume":"134","author":"Zhao","year":"2012","journal-title":"Schizophr. Res."},{"key":"B104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/brb3.1292","article-title":"CACNA1C (rs1006737) may be a susceptibility gene for schizophrenia: An updated meta-analysis","volume":"9","author":"Zhu","year":"2019","journal-title":"Brain Behav."},{"key":"B105","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1042\/bj20120674","article-title":"Antidepressants inhibit DNA methyltransferase 1 through reducing G9a levels","volume":"448","author":"Zimmermann","year":"2012","journal-title":"Biochem. J."},{"key":"B106","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jpsychires.2016.12.019","article-title":"Genetic and epigenetic regulation on the transcription of GABRB2: Genotype-dependent hydroxymethylation and methylation alterations in schizophrenia","volume":"88","author":"Zong","year":"2017","journal-title":"J. Psychiatr. Res."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2020.00467\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T08:36:13Z","timestamp":1587544573000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2020.00467\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,22]]},"references-count":106,"alternative-id":["10.3389\/fphar.2020.00467"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2020.00467","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,22]]},"article-number":"467"}}